Spontaneous closure of secondary full-thickness macular hole following pars plana vitrectomy for rhegmatogenous retinal detachment: a case report and literature review Authors: Afeng Li, Shuaiwei Chen, Bo Jiang Published: 2026 ABSTRACT PurposeSecondary full-thickness macular holes (sFTMHs) are rare complications following pars plana vitrectomy (PPV) for rhegmatogenous retinal detachment (RRD). Although surgical repair is standard, spontaneous closure occurs in a minority of cases. This report describes a case of spontaneous sFTMH closure and reviews the literature to elucidate associated factors and mechanisms.MethodsWe present a case of a 33-year-old male who developed a sFTMH after silicone oil removal following PPV for RRD. Additionally, a comprehensive PubMed literature search identified published cases of spontaneous sFTMH closure after RRD repair.ResultsThe patient's sFTMH closed spontaneously within three months, accompanied by improved visual acuity. A review of over 30 published cases reveals distinct pathogenic and resolution factors. Hole formation is driven by postoperative tangential traction from epiretinal membranes (ERM), cystoid macular edema (CME), surgical trauma, and inflammation, with high-altitude exposure as a notable environmental risk. Conversely, spontaneous closure is favored by a smaller hole diameter and the presence of epiretinal proliferation (EP) which may act as a scaffold for glial bridging, and often coincides with CME resolution, potentially accelerated by topical therapy. Mechanistically, closure is mediated by glial proliferation and tissue apposition under persistent epiretinal traction, combined with intraretinal fluid resorption, leading to variable restoration of the retinal laminar structure.ConclusionSpontaneous closure of sFTMHs after RRD surgery is a recognized phenomenon. For selected patients with small, minimally symptomatic holes associated with edema or EP, initial management with observation, potentially supplemented by topical therapy, is a viable strategy before considering surgery. Introduction A secondary full-thickness macular hole (sFTMH) is an uncommon complication following pars plana vitrectomy (PPV), with a reported incidence of approximately 0.24–0.4% [1, 2]. The most common surgical indication for the initial PPV preceding a sFTMH is rhegmatogenous retinal detachment (RRD) (76.7%), which represents 46 eyes in one cohort; the rest of the surgical indications comprise idiopathic epiretinal membrane (ERM) or vitreomacular traction (VMT), tractional retinal detachment, acute submacular hemorrhage, ocular trauma, and vitreous hemorrhage [2]. Notably, the documented incidence of sFTMH following PPV for RRD falls within the range of 0.28–1.93% [3–5]. Secondary macular holes (MHs) following RRD repair were initially identified after scleral buckling (SB) surgery, and the first cases were attributed to anteroposterior vitreomacular traction (VMT) due to persistent vitreous [6–8]. In contrast, sFTMHs that arise following PPV are mainly caused by tangential traction of an overlying ERM or epiretinal proliferation (EP) [3]. This traction typically necessitates surgical intervention to facilitate anatomical closure [2]. Although surgical repair remains the standard management, spontaneous closure of sFTMH is a recognized phenomenon, occurring in approximately 5–18% of cases [2, 3, 9]. Topical medical therapy has also been reported to facilitate closure in selected cases [10]. However, the factors that promote spontaneous closure remain poorly understood, largely due to the rarity of the event and a literature dominated by isolated case reports. To address this significant knowledge gap, we present a case of sFTMH closure following PPV for RRD. Furthermore, we analyze the characteristics of previously reported cases and explore the potential mechanisms underlying this phenomenon. Methods We conducted a retrospective study of a patient who developed a sFTMH after PPV for RRD. The initial surgery was performed in December 2024 at the Department of Ophthalmology, The First Affiliated Hospital, Zhejiang University School of Medicine. An ophthalmological assessment was performed during the first presentation and at subsequent postoperative follow-ups. Data collected included best-corrected visual acuity (BCVA), refractive error, anterior segment examination, intraocular pressure (IOP), axial length (AL), retinal status in detail, and spectral domain optical coherence tomography (SD-OCT; Spectralis, Heidelberg Engineering, Germany). An extensive literature review was conducted using PubMed to identify cases of sFTMH following PPV for RRD, with specific focus on cases of spontaneous closure. The search covered the period from database inception to March 31, 2026. The search employed the following combinations of keywords: “macular hole”, “spontaneous closure or closed spontaneously”, “vitrectomy”, and “rhegmatogenous retinal detachment”. The references cited in the retrieved articles were manually examined to identify additional pertinent publications. Cases involving a concurrent FTMH and RRD at presentation, as well as those with MH formation following the repair of tractional retinal detachment, were excluded from consideration. This study adhered to the tenets of the Declaration of Helsinki and was approved by the institutional review board of The First Affiliated Hospital, Zhejiang University School of Medicine. Written informed consent was obtained from the patient for the publication of this case report and accompanying clinical images. Results Case report A 33-year-old male presented with a 3-day history of acute visual field loss in his left eye (LE). On initial examination, BCVA was 20/20 in the right eye (RE) and 6/40 in the LE. Anterior segment examination was unremarkable in both eyes, with IOP of 19 mmHg in the RE and 15 mmHg in the LE. Fundus examination of the LE revealed a macula-on RRD with multiple inferior retinal breaks, alongside bilateral peripheral retinal degeneration. The patient had a myopic refractive error (spherical equivalent) of −3.0 diopters (AL 24.67 mm) in the RE and −2.5 diopters (AL 24.21 mm) in the LE. The patient underwent 23‑gauge PPV with endolaser retinopexy and silicone oil (SO) tamponade. Intraoperative triamcinolone acetonide staining confirmed a complete posterior vitreous detachment (PVD). At the one‑week postoperative visit, the retina was fully attached. Subsequent follow-up over the following months revealed a stable BCVA of 20/30 and normal macular architecture on OCT. Six months post-vitrectomy, the patient underwent SO removal combined with phacoemulsification and intraocular lens implantation, accompanied by a fluid–air exchange. One week after SO removal, BCVA was 20/30 with an attached retina. OCT imaging demonstrated a normal foveal contour but revealed focal EP, appearing as medium-reflective preretinal thickening (Fig. 1 A). Four weeks later, OCT showed early pathological changes, including perifoveal cystic spaces and disruption of the outer retinal architecture, with partial breaks in the outer nuclear layer (ONL) and discontinuity of the interdigitation zone (IZ) (Fig. 1 B). Two months post-SO removal, the patient reported decreased vision and metamorphopsia in the LE. BCVA declined to 20/50, and OCT confirmed a FTMH with a minimum linear diameter (MLD) of 99 μm and a basal diameter (BD) of 1303 μm. The hole was associated with a cuff of subretinal fluid elevating its edges and surrounding perifoveal cystic edema, along with a mild ERM, persistent EP, and multiple hyperreflective granular deposits on the retinal pigment epithelium (RPE) at the hole base (Fig. 1 C). Topical 0.1% fluorometholone and pranoprofen eye drops were prescribed three times daily upon the patient's request for observation. Three months post-SO removal, follow-up OCT demonstrated spontaneous closure of the MH. The external limiting membrane (ELM) was continuous, though the ellipsoid zone (EZ) and IZ remained partially disrupted. Mild ERM, EP, and residual perifoveal cystic changes were present (Fig. 1 D). By the final follow-up at six months post-SO removal (three months post-closure), the patient's metamorphopsia had resolved and BCVA improved to 20/30. OCT showed resolution of the cystic edema and restoration of the foveal contour, with only mild irregularity of the IZ persisting (Fig. 1 E).Fig. 1Optical coherence tomography (OCT) imaging following silicone oil removal. A One week after silicone oil (SO) removal, OCT revealed a normal foveal contour but showed focal epiretinal proliferation (EP), appearing as a medium-reflective preretinal thickening (white arrow). B At five weeks post-SO removal, early pathological changes were evident, including perifoveal cystic changes with disruption of the outer nuclear layer (ONL) and interdigitation zone (IZ). C Two months post-SO removal, a secondary full-thickness macular hole (sFTMH) had formed, featuring a subretinal fluid cuff, perifoveal cystic edema, a mild epiretinal membrane (ERM), persistent EP, and hyperreflective granular deposits at the base. D Three months post-SO removal, spontaneous closure of the macular hole was observed. The external limiting membrane (ELM) was continuous, while the ellipsoid zone (EZ) and IZ remained partially disrupted, with persistent mild ERM, EP, and cystic changes. E At the final follow-up five months post-SO removal, OCT showed resolution of cystic edema and restoration of the foveal contour, with only mild irregularity of the IZ persisting Optical coherence tomography (OCT) imaging following silicone oil removal. A One week after silicone oil (SO) removal, OCT revealed a normal foveal contour but showed focal epiretinal proliferation (EP), appearing as a medium-reflective preretinal thickening (white arrow). B At five weeks post-SO removal, early pathological changes were evident, including perifoveal cystic changes with disruption of the outer nuclear layer (ONL) and interdigitation zone (IZ). C Two months post-SO removal, a secondary full-thickness macular hole (sFTMH) had formed, featuring a subretinal fluid cuff, perifoveal cystic edema, a mild epiretinal membrane (ERM), persistent EP, and hyperreflective granular deposits at the base. D Three months post-SO removal, spontaneous closure of the macular hole was observed. The external limiting membrane (ELM) was continuous, while the ellipsoid zone (EZ) and IZ remained partially disrupted, with persistent mild ERM, EP, and cystic changes. E At the final follow-up five months post-SO removal, OCT showed resolution of cystic edema and restoration of the foveal contour, with only mild irregularity of the IZ persisting Discussion The delayed formation and subsequent spontaneous closure of a FTMH following vitrectomy for RRD is a rare occurrence. A review of the literature from 2007 to 2025, encompassing 17 studies (primarily retrospective series and case reports), identified over 30 reported cases of this phenomenon, which are summarized in Table 1. The affected patients ranged in age from 12 to 78 years, with a clustering between 50 and 65 years and no clear sex predilection. The use of various intraocular tamponades (silicone oil, SF6, C3F8, air) indicates that late MH formation is not agent-specific. Preoperative visual acuity varied widely, from 20/20 to light perception. Table 1Summary of reported cases with spontaneous closure of secondary full-thickness macular hole following pars plana vitrectomy for rhegmatogenous retinal detachmentRRDsFTMHFollow-upNoStudyCaseAgeSexBaseline BCVAMacula status (tamponade)Time from PPV to FTMH formation (mo)Time from PPV to FTMH closure (mo)MH Size(μm)OCT features at MH formationReopen (Y/N)Final BCVAFollow-up from PPV (mo)Structural outcome after MH closureRemarks1[11]case series1(case2)53FHMNR (SF6)0.335NRWatzke sign ( +)N1/10NRWatzke sign (−)Recurrent RRD2(case 3)60FLPNR (Air)29NRElevated cystic edgesN2/10NRRPE changes2[4]Retrospectivecase series1(Case 3)53F20/40Off (C3F8 + extraocular band)4849NRElevated cystic edges,ERMN20/5054Intact retinal layers,ERMPseudophakic3[12]case report158M20/200Off (SF6)0.51NRResidual cortex, VMTN20/401.5VMT resolved4[13]case report159M20/30On (C3F8)23NRElevated cystic edgesY(surgery)20/607Surgical closureMyopic pseudophakic eye with history of Nd:YAG capsulotomy and laser retinopexy5[14]Retrospectivecase series1(Patient 19)58M20/30On (NR)21.422.4Base: 222ERMN20/2037.4NR2(Patient 21)67F20/30On(PPV + SB)4.15.1Base: 74ERMN20/2513.1NR6[15]case series1(Case 1)47M20/32On(PPV + SB)3638189Elevated cystic edges,ERMN20/20 > 120Intact retinal layersHighly myopia,YAG capsulotomy7[16]two cases1(case 1)66MNRNR1011NRCME, ERM,Elevated cystic edges,EPY (Recurrent4 times over7 years)20/25 > 84ERM, EPHigh myopia8[17]case report157MLPOff (SO)0.030.46NRILM-like bridge under SON6/603Closed with glial tissue under SO9[18]case report145FHMOff (SO)2123Tiny (NR)Foveal thinning,EZ disruption, ERM,Elevated cystic edgesY (spontaneously closed again)20/4054Foveal contour regained, ERMPseudophakic10[19]case report149MNRNR(PPV + SB)Years1#NRPre-MH: Irregular fovealdepression, mild ERM;Active MH:Elevated cystic edgesY(spontaneously closed again)20/30NRMild EZ disruptionPseudophakic11[10]Retrospectivecase series1(Case 8)78MNRNRNR0.9377ERM, Cystic edgesN20/20011.5Topical therapy(difluprednate and brinzolamide)POAG,pseudophakic12[3]Retrospective review of9680 eyes465.8 †2F,2 M ~ 20/526Off (PPV/PPV + SB)2.71†4.58‡Min:161.8† Base: 621.5†ERM/EP in all eyesN ~ 20/85NRNRAll received topical prednisolone,1 received CAI,1 received NSAID13[9]Retrospectivecase series752†5 M,2F20/30†1/7 Off(SF6)36‡(range1–137)2† # (range 1–4)Min: 135‡ERM/EP (7/6)5 (2 spontaneously closed again)20/2469‡ (range35–157)Lamellar MH in 3/4 spontaneously closed eyes3/7 high myopia14[20]case series131FFC/20CMOff (SO)0.41Min:872Base: 2087Residual cortex,VMT bridgingN20/1005VMT resolved, thin foveaDuring pregnancy267M20/200Off (Air)0.31Min: 558Residual cortex,VMT bridgingN20/805VMT resolved, CME, ERMMyopia312FFC/30CMOff (SO)0.130.5tiny (NR)Residual cortex,VMT bridgingN20/2001VMT resolved, thin foveaUnder observation15[21]case report169M20/20On (SF₆)0.751.35NRElevated cystic edgesN20/256Intact retinal layersPseudophakic16[2]Retrospective review of 16939 patients3NRNRNRNR26.2‡ (42.4†)3‡#Min: 128†NRNNRNRNR17[22]case report160M20/50Off (SO)1830NRCystic edgesY (spontaneously closed again)NR52Focal EZ defectHigh-altitude exposure18Our case133M6/40ON (SO)89Min:99, Base: 1303Cystic edges, ERM, EP, hyperreflective granular depositsN20/3011Restored foveal contour,Mild IZ irregularityMyopia# Time from FTMH formation to closure†Mean‡MedianBCVA, best-corrected visual acuity; CAI, carbonic anhydrase inhibitor; CME, cystoid macular edema; EZ, ellipsoid zone; EP, epiretinal proliferation; ERM, epiretinal membrane; F, female; FTMH, full-thickness macular hole; HM, hand motion; ILM, internal limiting membrane; IZ, interdigitation zone; LP, light perception; M, male; Min, minimum diameter; NR, not reported; NSAID, non-steroidal anti-inflammatory drug; OCT, optical coherence tomography; PPV, pars plana vitrectomy; RPE, retinal pigment epithelium; RRD, rhegmatogenous retinal detachment; SO, silicone oil; VMT, vitreomacular traction Table 1Summary of reported cases with spontaneous closure of secondary full-thickness macular hole following pars plana vitrectomy for rhegmatogenous retinal detachmentRRDsFTMHFollow-upNoStudyCaseAgeSexBaseline BCVAMacula status (tamponade)Time from PPV to FTMH formation (mo)Time from PPV to FTMH closure (mo)MH Size(μm)OCT features at MH formationReopen (Y/N)Final BCVAFollow-up from PPV (mo)Structural outcome after MH closureRemarks1[11]case series1(case2)53FHMNR (SF6)0.335NRWatzke sign ( +)N1/10NRWatzke sign (−)Recurrent RRD2(case 3)60FLPNR (Air)29NRElevated cystic edgesN2/10NRRPE changes2[4]Retrospectivecase series1(Case 3)53F20/40Off (C3F8 + extraocular band)4849NRElevated cystic edges,ERMN20/5054Intact retinal layers,ERMPseudophakic3[12]case report158M20/200Off (SF6)0.51NRResidual cortex, VMTN20/401.5VMT resolved4[13]case report159M20/30On (C3F8)23NRElevated cystic edgesY(surgery)20/607Surgical closureMyopic pseudophakic eye with history of Nd:YAG capsulotomy and laser retinopexy5[14]Retrospectivecase series1(Patient 19)58M20/30On (NR)21.422.4Base: 222ERMN20/2037.4NR2(Patient 21)67F20/30On(PPV + SB)4.15.1Base: 74ERMN20/2513.1NR6[15]case series1(Case 1)47M20/32On(PPV + SB)3638189Elevated cystic edges,ERMN20/20 > 120Intact retinal layersHighly myopia,YAG capsulotomy7[16]two cases1(case 1)66MNRNR1011NRCME, ERM,Elevated cystic edges,EPY (Recurrent4 times over7 years)20/25 > 84ERM, EPHigh myopia8[17]case report157MLPOff (SO)0.030.46NRILM-like bridge under SON6/603Closed with glial tissue under SO9[18]case report145FHMOff (SO)2123Tiny (NR)Foveal thinning,EZ disruption, ERM,Elevated cystic edgesY (spontaneously closed again)20/4054Foveal contour regained, ERMPseudophakic10[19]case report149MNRNR(PPV + SB)Years1#NRPre-MH: Irregular fovealdepression, mild ERM;Active MH:Elevated cystic edgesY(spontaneously closed again)20/30NRMild EZ disruptionPseudophakic11[10]Retrospectivecase series1(Case 8)78MNRNRNR0.9377ERM, Cystic edgesN20/20011.5Topical therapy(difluprednate and brinzolamide)POAG,pseudophakic12[3]Retrospective review of9680 eyes465.8 †2F,2 M ~ 20/526Off (PPV/PPV + SB)2.71†4.58‡Min:161.8† Base: 621.5†ERM/EP in all eyesN ~ 20/85NRNRAll received topical prednisolone,1 received CAI,1 received NSAID13[9]Retrospectivecase series752†5 M,2F20/30†1/7 Off(SF6)36‡(range1–137)2† # (range 1–4)Min: 135‡ERM/EP (7/6)5 (2 spontaneously closed again)20/2469‡ (range35–157)Lamellar MH in 3/4 spontaneously closed eyes3/7 high myopia14[20]case series131FFC/20CMOff (SO)0.41Min:872Base: 2087Residual cortex,VMT bridgingN20/1005VMT resolved, thin foveaDuring pregnancy267M20/200Off (Air)0.31Min: 558Residual cortex,VMT bridgingN20/805VMT resolved, CME, ERMMyopia312FFC/30CMOff (SO)0.130.5tiny (NR)Residual cortex,VMT bridgingN20/2001VMT resolved, thin foveaUnder observation15[21]case report169M20/20On (SF₆)0.751.35NRElevated cystic edgesN20/256Intact retinal layersPseudophakic16[2]Retrospective review of 16939 patients3NRNRNRNR26.2‡ (42.4†)3‡#Min: 128†NRNNRNRNR17[22]case report160M20/50Off (SO)1830NRCystic edgesY (spontaneously closed again)NR52Focal EZ defectHigh-altitude exposure18Our case133M6/40ON (SO)89Min:99, Base: 1303Cystic edges, ERM, EP, hyperreflective granular depositsN20/3011Restored foveal contour,Mild IZ irregularityMyopia# Time from FTMH formation to closure†Mean‡MedianBCVA, best-corrected visual acuity; CAI, carbonic anhydrase inhibitor; CME, cystoid macular edema; EZ, ellipsoid zone; EP, epiretinal proliferation; ERM, epiretinal membrane; F, female; FTMH, full-thickness macular hole; HM, hand motion; ILM, internal limiting membrane; IZ, interdigitation zone; LP, light perception; M, male; Min, minimum diameter; NR, not reported; NSAID, non-steroidal anti-inflammatory drug; OCT, optical coherence tomography; PPV, pars plana vitrectomy; RPE, retinal pigment epithelium; RRD, rhegmatogenous retinal detachment; SO, silicone oil; VMT, vitreomacular traction Summary of reported cases with spontaneous closure of secondary full-thickness macular hole following pars plana vitrectomy for rhegmatogenous retinal detachment [11] case series 1 (case2) 2 (case 3) [4] Retrospective case series 1 (Case 3) Off (C3F8 + extraocular band) Elevated cystic edges, ERM Intact retinal layers, ERM [12] case report [13] case report Y (surgery) [14] Retrospective case series 1 (Patient 19) 2 (Patient 21) On (PPV + SB) [15] case series 1 (Case 1) On (PPV + SB) Elevated cystic edges, ERM Highly myopia, YAG capsulotomy [16] two cases 1 (case 1) CME, ERM, Elevated cystic edges, EP Y (Recurrent 4 times over 7 years) [17] case report [18] case report Foveal thinning, EZ disruption, ERM, Elevated cystic edges [19] case report NR (PPV + SB) Pre-MH: Irregular foveal depression, mild ERM; Active MH: Elevated cystic edges Y (spontaneously closed again) [10] Retrospective case series 1 (Case 8) Topical therapy (difluprednate and brinzolamide) POAG, pseudophakic [3] Retrospective review of 9680 eyes 2F, 2 M Off (PPV /PPV + SB) All received topical prednisolone, 1 received CAI, 1 received NSAID [9] Retrospective case series 1/7 Off (SF6) 36‡ (range 1–137) 69‡ (range 35–157) [20] case series Min:872 Base: 2087 Residual cortex, VMT bridging Residual cortex, VMT bridging Residual cortex, VMT bridging [21] case report [2] Retrospective review of 16939 patients [22] case report Restored foveal contour, Mild IZ irregularity # Time from FTMH formation to closure †Mean ‡Median BCVA, best-corrected visual acuity; CAI, carbonic anhydrase inhibitor; CME, cystoid macular edema; EZ, ellipsoid zone; EP, epiretinal proliferation; ERM, epiretinal membrane; F, female; FTMH, full-thickness macular hole; HM, hand motion; ILM, internal limiting membrane; IZ, interdigitation zone; LP, light perception; M, male; Min, minimum diameter; NR, not reported; NSAID, non-steroidal anti-inflammatory drug; OCT, optical coherence tomography; PPV, pars plana vitrectomy; RPE, retinal pigment epithelium; RRD, rhegmatogenous retinal detachment; SO, silicone oil; VMT, vitreomacular traction Reported dimensions of sFTMHs varied considerably, with MLD ranging from 77 μm to 872 μm and BD from 74 μm to 2087 μm; some reports provided only qualitative descriptions (for example, "tiny") or lacked precise measurements entirely. The typical OCT appearances at diagnosis included elevated cystic edges or perifoveal cystic changes, ERM, EP, cystoid macular edema (CME), residual vitreous cortex or VMT, hyperreflective granular deposits on the RPE, and an internal limiting membrane (ILM)-like bridging structure. Compared to primary idiopathic FTMHs (iFTMHs), sFTMHs more frequently exhibit a morphological cuff of elevated subretinal fluid at the hole edges. This morphological difference suggests that tangential traction is stronger in sFTMHs, elevating the hole edges [2]. Moreover, hyperreflective supra-RPE granular deposition in the base of the hole is a common observation in sFTMHs, and the prevalence of this finding is reported to be more elevated than in iFTMHs (50% versus 33%) [2]. These deposits are probably residual outer segments of the photoreceptors, meaning that there is simultaneous photoreceptor injury and recovery process [23]. The interval between vitrectomy and FTMH formation varied widely, ranging from one day to over 11 years after surgery. A high percentage of cases were reported within the first three postoperative months, a time interval that can probably be explained by the acute nature of the processes including surgical trauma, residual vitreous traction, early inflammation, or tamponade mechanisms [12, 17, 20]. Conversely, some FTMHs formed many years following the original surgery [4, 15, 22], and in one of the large sample studies, a mean formation period of 42.4 months was reported. The pathogenesis of such late-presenting cases may involve slow and progressive processes like ERM proliferation and contraction, chronic cystic changes, or enduring microalterations of the ocular environment [2]. The exact pathophysiology contributing to acute postoperative MHs development has not been fully clarified, but evidence suggests a multifactorial pathogenesis, broadly categorized into direct mechanical trauma and biochemical inflammatory responses [12, 17, 20]. Direct iatrogenic damage can involve intraoperative macular trauma because of high-velocity fluid infusion, accidental instrument contact, or excessive traction during PVD induction [17, 20, 24]. Simultaneously, the contributory biochemical mechanisms include phototoxicity, inflammatory response induced by lasers and silicone oil, ischemic damage, and coalescence of microcysts [17]. This iatrogenic model gains strong clinical support from the observation that approximately 60% of secondary macular holes are detected within three months of vitrectomy [1]. The potential for spontaneous closure indicates that postoperative inflammation may initiate a reparative response, not solely exert destructive effects [11]. Imaging studies have directly visualized this inflammatory pathway, revealing a transient, ILM-like hyperreflective bridge in eyes filled with silicone oil. This structure, interpreted as an acute fibrinous membrane, emerges and subsequently resolves, potentially serving as a scaffold for natural healing processes [17]. Tangential traction that is persistent or emerges during the postoperative period is a fundamental process in the pathogenesis of MHs, which mainly originates from two sources: residual vitreous cortex and proliferative ERM. The complete intraoperative removal of the prefoveal vitreous cortex remains a significant technical challenge, even with the aid of triamcinolone for enhanced visualization. This residual cortex may subsequently contract, exerting direct traction on the fovea, a process that is analogous to VMT syndrome, as supported by recent case studies [20]. ERM is a more widespread and more significant source of traction. It has been consistently observed that the incidence of ERM formation following retinal detachment surgery in cases involving MHs is remarkably high, with reported rates reaching up to 100% [14, 25]. Its etiology is associated with blood–retinal barrier disruption in the postoperative period, retinal pigment epithelial (RPE) migration and glial cell activation and growth [2, 26]. If the ILM remains intact during the initial surgery, it may act as a scaffold for this cellular growth [2]. This contraction of the ERM causes sustained tangential forces which alter the macular microstructure, promoting the formation of submacular cysts and, ultimately, full-thickness holes. The ischemic and hypoxic environment associated with a preoperative macular detachment may not only facilitate ERM, but also compromise the foveal tissue, making it more vulnerable to tractional failure [20]. Histopathological analysis of peeled membranes directly confirms ERM-mediated traction, demonstrating a periodic acid–Schiff (PAS)-positive ILM with associated fibrocellular tissue at its edges [13]. The foveal crack sign (FCS) provides direct, dynamic evidence of ERM-induced traction. On OCT imaging, it presents as a vertical hyperreflective line traversing the fovea with associated contour distortion [5]. This is a typical manifestation that develops after parafoveal ERM development and is frequently observed in patients who develop FTMH after repair of RRD [5, 19]. FCS is regarded as a morphological marker indicating that tangential anatomical stress from the ERM has reached a critical state, potentially serving as a precursor to full-thickness hole formation [5]. Therefore, its appearance in postoperative patients with parafoveal ERM should be closely and long-term followed. In addition to the tangential traction process, postoperative MH can also develop through a "cystoid degeneration" process centered on CME. Preoperative macular detachment may cause ischemia, hypoxia, and dysfunction of the RPE-choriocapillaris complex, resulting in the intraretinal fluid accumulation and CME after surgery [27, 28]. The subsequent coalescence and rupture of these cystoid spaces may ultimately result in full-thickness hole formation. At the same time, the reattached macular tissue has different biomechanical characteristics; having been swollen and weakened by detachment, it becomes less resistant to external traction and inner hydraulic pressure [1]. This structural vulnerability consequently elevates the macula's susceptibility to hole formation. Supporting this, Bhatnagar et al. found in a retrospective analysis that postoperative macular edema constituted an independent risk factor for reopened macular holes, associated with an odds ratio of approximately 7 [29]. High-altitude exposure represents a unique environmental risk factor for MH development, primarily mediated through exacerbation of ischemic-hypoxic injury and induction of CME [30]. The physiological changes associated with these conditions, including increased blood viscosity and reduced oxygen delivery, disrupt the integrity of the inner blood–retinal barrier, leading to fluid accumulation and the development of CME [31–33]. This pathophysiology is consistent with the previously described ‘cystoid degeneration’ mechanism. Notably, this environmental impact is dynamic and reversible. A documented case demonstrates that a MH with parafoveal CME formed after ascent to high altitude (~ 2500 m) closed spontaneously upon return to low altitude (~ 24 m)—a cycle that repeated with re-exposure. Such a pattern suggests that the hypoxic high-altitude environment can induce and sustain macular edema, driving a chronic pathological process, while normoxia at low altitude allows spontaneous recovery. This structural repair is attributed to cellular mediators like Muller glia during the resolution phase [34]. Spontaneous closure of sFTMHs typically occurs within one to four months after its detection (Table 1), with reported intervals ranging from 10 days to 10 months. Importantly, this closure can be unstable. Some cases exhibit a dynamic cycle of opening and closing phases, with one report noting five recurrences and spontaneous re-closures over seven years [16]. This instability is reflected in a high re-opening rate, reported to be as high as 71% after spontaneous closure [9]. Considering this natural history, a clinical observation period of about 2–3 months may be appropriate for certain cases, as spontaneous closure typically occurs at a median of 56 days, compared to 18.5 days for surgical intervention [2, 3]. During this period, close monitoring with OCT is advised. Surgical intervention should be considered if the hole enlarges, visual acuity declines, or traction persists. Spontaneously closing holes usually have a smaller MLD of 128–162 μm, while those that remain open range from 387–589 μm [2, 3, 9]. This correlation is mechanistically attributed to the bridging and scaffolding effects of epiretinal proliferation and Müller glial cells, which more effectively span and repair smaller defects. The spontaneous closure of a FTMH demonstrates the intrinsic reparative capacity of the retina. For idiopathic FTMHs, a complete PVD is necessary to remove anteroposterior VMT, thereby facilitating internal bridging through the proliferation and migration of retinal glial cells (for example, Müller cells) to fill the tissue defect [35–37], and external approximation of the hole edges via the centripetal contraction of an ERM [37, 38]. Ultimately, anatomical closure is achieved through the bridging of the inner retinal layers [39]. Significantly, spontaneous closure can also occur in vitrectomized eyes even in the absence of vitreous traction. In this postoperative scenario, closure is primarily dependent on tangential ERM contraction, the development of bridging glial tissue, and EP [9, 14, 15]. A critical element in this repair process is the bridging tissue that covers the hole. Histological evidence indicates this tissue consists of hyperplastic glial and Müller cells [40]. Its presence on OCT often signals impending closure and is linked to a higher chance of spontaneous healing, especially in younger patients or those with shorter symptom durations [31]. The formation of this bridge is facilitated by the centripetal traction of an ERM, which pulls the hole edges together and stimulates anterior retinal tissue proliferation [41]. Subsequently, the bridging tissue may promote the regeneration of the ONL and ELM, crucial for stable anatomical closure [31, 42]. Regarding EP, it was initially characterized as a thicker, denser variant of a conventional ERM, frequently observed in association with lamellar MHs [43–45]. Histologically, EP primarily consists of proliferated Müller cells extending to the retinal inner surface, a finding noted in both lamellar and FTMHs [42]. Although commonly present in secondary MHs following retinal detachment repair, EP itself lacks intrinsic contractile properties, and its direct pathogenic role in hole formation remains unclear. Intriguingly, evidence suggests EP may be associated with spontaneous closure [2, 9, 46]. For instance, a higher rate of spontaneous closure was reported for macular holes with concurrent EP after vitrectomy for RRD, implying a potential facilitatory role via Müller cell migration and proliferation [9, 30]. This is supported by OCT observations showing that the reparative tissue bridging the closing hole shares reflective properties similar to adjacent EP [42, 46]. Additionally, spontaneous closure of small postoperative macular holes accompanied by ERM or EP suggests that ILM remodeling and alterations in the cellular microenvironment may also contribute to this reparative process [15]. For small, sFTMHs associated with CME, topical pharmacotherapy offers a potential non-surgical intervention. Reported regimens primarily include topical corticosteroids (for example, difluprednate), non-steroidal anti-inflammatory drugs (NSAIDs; for example, ketorolac, bromfenac), and carbonic anhydrase inhibitors (CAIs; for example, dorzolamide, brinzolamide, or oral acetazolamide), often used in combination [10, 47, 48]. For example, a study by Niffenegger et al. reported that in 9 eyes with sFTMH treated with topical therapy (difluprednate, with some also receiving CAIs or NSAIDs), 8 eyes (89%) experienced hole closure and CME resolution after about 6 weeks, with visual acuity improving from 20/100 to 20/50 [10]. This improvement is attributed to the reduction of CME and local inflammation, which decreases intraretinal fluid, promotes reapposition of the hole edges, and stabilizes the microenvironment to facilitate retinal self-repair [10]. Thus, topical pharmacotherapy serves as a viable and well-tolerated initial or conservative management option, possibly avoiding or delaying surgery. The degree of retinal layer restoration following spontaneous closure of a sFTMH is a critical determinant of final visual acuity. This healing process typically begins with bridging glial proliferation across the inner retinal layers and is usually completed within 3–4 months of diagnosis [19, 49]. Histological and imaging studies reveal a consistent pattern of differential regeneration among the outer retinal layers. The ONL and ELM demonstrate a robust regenerative capacity, with restoration rates as high as 100% for the ONL and 90% for the ELM in non-vitrectomized eyes, and similarly high rates observed post-vitrectomy [15, 31]. In contrast, regeneration of the EZ is often incomplete and occurs less frequently, with rates of 60% in Morawski's study and 33% in Zhang's study. This may be due to persistent tangential traction from associated ERM or EP [15, 31, 42]. Thus, even after anatomical hole closes, ongoing defects in the outer retinal microstructure, especially in the EZ, often hinder significant visual improvement [50]. Conversely, instances of successful EZ restoration are consistently correlated with enhanced visual outcomes [21, 31]. This structured, layer-specific repair sequence is hypothesized to reflect a reactivation of the developmental mechanism of foveation at the cellular level [51]. Conclusion sFTMHs following PPV for RRD repair represent a significant, vision-threatening complication. This case and literature review elucidate their distinct pathogenesis and clinical behavior. Unlike idiopathic macular holes, sFTMH development is strongly associated with persistent postoperative tangential traction, typically from an ERM and CME, with OCT often showing a characteristic subretinal fluid "cuff". Evidence confirms that spontaneous closure is a viable outcome for a selected subgroup, particularly holes with a small MLD associated with CME or EP. This reparative process depends on a dynamic interplay between the intraocular microenvironment, glial cell activity, and tractional forces. Consequently, immediate surgery is not universally required. For eligible cases, an initial management strategy of close observation for 2–3 months, potentially supplemented with topical anti-inflammatory therapy to reduce edema, represents a reasonable approach. Surgical intervention should be pursued if the hole enlarges, visual acuity deteriorates, or signs of progressive traction (for example, FCS) develop during observation. Future research should focus on identifying precise predictors of spontaneous sFTMH closure, such as specific OCT biomarkers and morphological characteristics, and on evaluating the long-term comparative effectiveness of different management strategies (observation, medical therapy, and surgery). Multicenter prospective studies are warranted to establish evidence-based, individualized treatment pathways. However, our conclusions are limited by the rarity of spontaneous closure, potential publication bias, and the lack of comparative data.